Publications by authors named "Karen D Howarth"

Claim this Profile
N
NRG1 fusions in breast cancer.
Karen D Howarth, Tashfina Mirza, Susanna L Cooke, Suet-Feung Chin, Jessica C Pole

Breast Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAF amplification whereas KRAS amplification promotes EMT-chemoresistance.
Matthew J Sale, Kathryn Balmanno, Jayeta Saxena, Eiko Ozono, Katarzyna Wojdyla, Karen D Howarth

Nat Commun· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Michael A Pritchett, D Ross Camidge, Manu Patel, Jamil Khatri, Steven Boniol, Karen D Howarth

JCO Precis Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone.
Sara Gm Piccirillo, Inmaculada Spiteri, Andrea Sottoriva, Anestis Touloumis, Suzan Ber, Karen D Howarth

Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative timing of mutations in a breast cancer genome.
Scott Newman, Karen D Howarth, Chris D Greenman, Graham R Bignell, Simon Tavaré

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation.
Claire L Cope, Rebecca Gilley, Kathryn Balmanno, Matthew J Sale, Karen D Howarth

J Cell Sci· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes.
Ina Schulte, Elizabeth M Batty, Jessica C M Pole, Katherine A Blood, Steven Mo, Karen D Howarth

BMC Genomics· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes.
David J McBride, Dariush Etemadmoghadam, Susanna L Cooke, Kathryn Alsop, Joshy George, Karen D Howarth

J Pathol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are breast cancers driven by fusion genes?
Paul A W Edwards, Karen D Howarth

Breast Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-molecule analysis of genome rearrangements in cancer.
Jessica C M Pole, Frank McCaughan, Scott Newman, Karen D Howarth, Paul H Dear

Nucleic Acids Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large duplications at reciprocal translocation breakpoints that might be the counterpart of large deletions and could arise from stalled replication bubbles.
Karen D Howarth, Jessica C M Pole, Juliet C Beavis, Elizabeth M Batty, Scott Newman

Genome Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis